News

Archive

June 20, 2018

Deciphera Pharmaceuticals Announces Full Exercise of Underwriters' Option to Purchase Additional Shares

Archive

June 13, 2018

Deciphera Pharmaceuticals, Inc. to Present at the JMP Securities 2018 Life Sciences Conference

Archive

June 11, 2018

Deciphera Pharmaceuticals Announces Closing of Public Offering of Common Stock

Archive

June 6, 2018

Deciphera Pharmaceuticals Announces Pricing of Public Offering

Archive

June 4, 2018

Deciphera Pharmaceuticals Announces Proposed Public Offering of Common Stock

Archive

June 2, 2018

Deciphera Pharmaceuticals Reports Updated Interim Phase 1 Clinical Study Results with DCC-2618 at The 2018 American Society of Clinical Oncology Annual Meeting (ASCO) and Provides Additional Clinical and Regulatory Updates on DCC-2618

Archive

May 29, 2018

Deciphera Pharmaceuticals Appoints Stephen B. Ruddy, Ph.D. as Chief Technical Officer

Archive

May 21, 2018

Deciphera Pharmaceuticals Expands Board with the Election of Mr. Steven L. Hoerter as a Director

Archive

May 14, 2018

Deciphera Pharmaceuticals, Inc. to Present at Upcoming Investor Conferences

Archive

May 8, 2018

Deciphera Pharmaceuticals, Inc. Announces First Quarter 2018 Financial Results

Back to top